[Use of 0.3% diflucortolone valerate in the topical treatment of steroid-sensitive dermatitis].
D001623:Betamethasone / Q000008:administration & dosage / Q000031:analogs & derivatives; D002986:Clinical Trials as Topic; D004060:Diflucortolone / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004311:Double-Blind Method; D004361:Drug Tolerance; D004485:Eczema / Q000188:drug therapy; D005260:Female; D005448:Fluocortolone / Q000031:analogs & derivatives*; D008297:Male; D009824:Ointments; D011565:Psoriasis / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*
D009824:Ointments; C013486:diflucortolone valerate; D005448:Fluocortolone; C011175:betamethasone-17,21-dipropionate; D001623:Betamethasone; D004060:Diflucortolone
Impiego del difluocortolone valerianato 0.3% per uso topico in dermatiti steroido-sensibili.